Sapylin Versus Dexamethasone Inhalation for CCRT-Induced Oral Mucositis in Nasopharyngeal Carcinoma

NCT07327216 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

180

Enrollment

OTHER

Sponsor class

Conditions

Nasopharyngeal Carcinoma (NPC)

Interventions

DRUG: Sapylin
DRUG: Dexamethasone
COMBINATION_PRODUCT: CCRT with Cisplatin

Sponsor

Affiliated Hospital of Guangdong Medical University